Oxaliplatin Interactions
There are 630 drugs known to interact with oxaliplatin, along with 7 disease interactions. Of the total drug interactions, 112 are major, 517 are moderate, and 1 is minor.
- View all 630 medications that may interact with oxaliplatin
- View oxaliplatin disease interactions (7)
Most frequently checked interactions
View interaction reports for oxaliplatin and the medicines listed below.
- Aloxi (palonosetron)
- Ativan (lorazepam)
- Avastin (bevacizumab)
- Benadryl (diphenhydramine)
- Claritin (loratadine)
- Colace (docusate)
- Compazine (prochlorperazine)
- Creon (pancrelipase)
- Decadron (dexamethasone)
- Eliquis (apixaban)
- Fentanyl Transdermal System (fentanyl)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Imodium (loperamide)
- Keytruda (pembrolizumab)
- Lomotil (atropine / diphenoxylate)
- Lovenox (enoxaparin)
- Metoprolol Succinate ER (metoprolol)
- MiraLAX (polyethylene glycol 3350)
- Mucinex (guaifenesin)
- Neulasta (pegfilgrastim)
- Norco (acetaminophen / hydrocodone)
- Paracetamol (acetaminophen)
- Quercetin (bioflavonoids)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xeloda (capecitabine)
- Zofran (ondansetron)
Oxaliplatin disease interactions
There are 7 disease interactions with oxaliplatin which include:
- arrhythmias
- pulmonary toxicity
- neurologic toxicity
- neutropenia
- renal impairment
- rhabdomyolysis
- thrombocytopenia
More about oxaliplatin
- oxaliplatin consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.